AXA Investment Managers Paris
The Artemis Insurance-Linked Securities Investment Managers & Funds Directory is a one-stop resource for information on insurance or reinsurance linked investment managers and their ILS fund strategies.
AXA Investment Managers Paris - Snapshot:
- ILS manager or company name: AXA Investment Managers Paris
- Location (HQ / Domicile): Paris, France
- Date of launch: Sep 2007
- Assets under management *: $551 million (as at December 31st 2015)
- Website link: AXA Investment Managers Paris website
AXA Investment Managers Paris - Details
The ILS strategies are managed by the ILS team based in Paris, France. The ILS team is a dedicated team focused on analysing and investing in the full spectrum of ILS globally.
The team is part of the wider AXA Structured Finance (AXA SF) division of AXA IM, a key participant in asset backed securities, ILS and leveraged loan instruments. Established in 2000, AXA Structured Finance is one of the largest structured finance platforms in Europe, managing close to €20 billion of assets under management, as at 30/09/2015.
Team size and structure:Within AXA SF, the ILS team includes: - 1 Head of ILS team - 2 Portfolio Managers / Analysts - 2 quantitative analyst. The ILS team also relies on the inputs from three teams within its parent company, the AXA Group: AXA Group Risk Management, AXA Global P&C and AXA Global Life, in terms of modelling and research capacities. The team also relies on AXA IM’s shared functions (risk management, legal, etc.).
Number of strategies (how many funds, sidecars or strategies):
Offers private managed accounts?
Through AXA SF’s affiliation with one of the largest insurance companies in the world – AXA Group – the ILS team is at the crossroads of the capital markets and insurance markets. This is an advantageous position for managing investments in ILS where knowledge of both markets is required to be able to correctly assess these securities.
The ILS team benefits from the strong on-going support of the AXA Group thanks to two specialized teams: AXA Group’s Risk Management (“GRM”) department provides invaluable assistance in terms of modelling and research capacities. This is formalized with an advisory agreement and through weekly meetings. AXA Global P&C and Global Life, the subsidiary of the AXA Group in charge of relationships with reinsurance companies enables the team to collect information on reinsurance market trends.
In order to avoid any conflict of interest, the ILS team’s relationship with the AXA Group is strictly limited to obtaining modelling and market information. All investment decisions are made exclusively by the ILS team. Moreover, the ILS team’s portfolios do not include any AXA insurance risk.
As at December end 2015, our ILS track record has shown a consistently attractive risk/return over the years, with more than 25% cumulative net return on our lower risk strategy, since inception in 2010, while our higher risk strategy generated close to 50% cumulative net return, since inception in 2011. Our strategy, that sits in between the above mentioned strategies, has performed more than 7% since inception in 2014.
AuM development: 2008: $300 million, 2009: €50 million, 2010: $118 million, 2011: $181 million, 2012: $284 million, 2013: $432 million, 2014: $506 million, 2015: $551 million
The Artemis Insurance-Linked Securities Investment Managers & Funds Directory is provided as-is. Best efforts are made to ensure the contents are accurate at the time of publication but there may be some omissions. Please contact Artemis should you require a change to your listing.
This material is used for informational purposes only and does not constitute, on AXA Investment Managers Paris’ (“AXA IM”) part, an offer to buy or sell, solicitation or investment advice in any particular product or strategy.
The attention of each recipient is drawn to the fact that, as of today, the strategy described in this document is not developed into a fund marketed in a lot of jurisdictions (in particular, but without limitation, in France). AXA IM may however study the implementation of this strategy, at a recipient‘s request, through a dedicated fund or a mandate.
This material contains historical market data and past performance; however, historical market trends are not reliable indicators of future market behaviour and past performance is not representative of future performance. Any historical investment results described in this material are not indicative of the future investment results. Such results are intended only to give indicative information. No representation is made by AXA IM or any other person that any indicative figures will be achieved.
Unless otherwise noted, information provided herein is current as of September 2014. This material may be modified without notice and AXA IM shall not be obligated, update or otherwise revise this document. All information in this material is established on the accounting information or on market data basis. The accounting information contained in this material may be un-audited.
This material is based upon information that AXA IM considers reliable, but AXA IM does not represent that it is accurate or complete, and it should not be relied upon as such. AXA IM makes no representation or warranty, express or implied, as to the fairness, accuracy or completeness of the information contained herein. AXA IM disclaims any and all liability relating to a decision based on or for reliance on this material.
IMPORTANT INFORMATION: AXA Group Risk Management, AXA Global P&C and AXA Global Life which are only sharing some of their respective expertise with AXA IM on specific topics disclaim any and all responsibilities, obligations and liability with respect to such sharing of expertise and to any decisions or advice made or given as a result of the information or use thereof
Source: AXA Investment Managers Paris.
The Artemis Insurance-Linked Securities Investment Managers & Funds Directory is copyright © Steve Evans Ltd. Reproduction, copying or publication without permission is not permitted. Use of this information within a commercial product, or for profit, without a license is strictly prohibited. Contact us if you would like to use this content or to discuss licensing.